key: cord-0735560-puuz47rl
authors: Böncüoğlu, Elif; Coşkun, Mehmet; Kıymet, Elif; Öztürk Atasoy, Tülay; Şahinkaya, Şahika; Cem, Ela; Düzgöl, Mine; Yılmaz Çelebi, Miray; Akaslan Kara, Aybüke; Arıkan, Kamile Ö.; Bayram, Nuri; Devrim, İlker
title: Can laboratory findings predict pulmonary involvement in children with COVID‐19 infection?
date: 2021-05-13
journal: Pediatr Pulmonol
DOI: 10.1002/ppul.25452
sha: 45b812a08e6bf5fa0533927725d897266d91d041
doc_id: 735560
cord_uid: puuz47rl

BACKGROUND: Studies investigating clinical and imaging findings of coronavirus disease 2019 (COVID‐19) pneumonia and predictors for lung injury mostly focus on adults. In this study, we aimed to evaluate the role of laboratory findings in predicting lung involvement in children with COVID‐19. METHODS: Children with COVID‐19 confirmed by reverse‐transcription polymerase chain reaction or COVID‐19 IgM and who underwent chest computed tomography (CT) scans were reviewed retrospectively. Admission absolute neutrophil count (ANC), absolute lymphocyte count (ALC), ANC/ALC ratio, platelet count, d‐dimer, fibrinogen, ferritin, procalcitonin, C‐reactive protein (CRP), and lactate dehydrogenase levels were compared in patients with normal and abnormal CT scans. RESULTS: A total of 101 children were included. Among the patients, 68 (67.3%) had normal CT scans, and 33 (32.7%) had pulmonary involvement. The median CRP, ferritin, and fibrinogen levels were significantly higher in children with abnormal CT findings. The model of binary logistic regression based on the presence of cough, shortness of breath, fibrinogen, ferritin, and CRP levels showed that the possibility of having abnormal CT was 1.021 times more likely for every one unit increase in fibrinogen levels. CONCLUSION: Fibrinogen might be useful to predict pulmonary involvement of COVID‐19 in children. Restricting radiological imaging to patients with significant symptoms and high fibrinogen levels might be helpful in children with COVID‐19 infections.

were obtained from the electronic medical record system. Chest CT scans of the patients were reviewed by two radiology specialists. The extent of lung involvement was scored as a percentage of the total lung area: score 1, 1%-5% involvement; score 2, 6%-25% involvement; score 3, 26%-50% involvement; score 4, 51%-75% involvement; and score 5, greater than 75% involvement.

Statistical analysis was performed using SPSS statistical software (version 22; SPSS). Measurement data with normal distribution are expressed as mean ± standard deviation (mean ± SD). The Student's t-test was used to compare continuous parametric variables, the Mann-Whitney U test was used to compare continuous nonparametric variables, and χ 2 was used for categorical variables. A twotailed p value of less than .05 was considered to be statistically significant. The odds ratio (95% CI) was calculated for risk factors for positive. CT findings and dependent variables with p < .05 were included in the univariate analysis. Adjusted odds ratios for risk factors were determined by using these variables in a stepwise forward logistic regression model. Ethics approval for this study was obtained from the Institutional Review Board of Dr. Behçet Uz Children's Hospital.

One hundred and one children with confirmed COVID-19 infection and pulmonary CT scans were included in the study. Of the patients, 47 (46.5%) were male and 54 (53.5%) were female. The mean age of the patients was 14.1 ± 2.4 years (range 6-18 years). Regarding the age distribution, 22.8% of the patients were between 6 and 12 years, 77.2% were 13 years and over. The most common presenting symptoms were fever (43.6%) and cough (33.7%) ( Table 1 ). In the group with pulmonary involvement based on CT findings, the mean age was 13.7 ± 2.8 years (ages 6-18) and there were 17 males (51.5%) and 16 females (48.5%); while in the group without pulmonary involvement, the mean age was 14.3 ± 2.1 years (ages 9-18) there were 30 males (44.1%) and 38 females (55.9%). There was no significant statistical difference of gender and mean age between the two groups (p > .05). The most common presenting symptom was fever (45.5% vs. 42.6%) in both groups. The mean duration of fever was 2.85 ± 2.04 days (range 1-6 days) in the group with pulmonary involvement and 1.83 ± 1.34 days (range 1-7 days) in the group without pulmonary involvement. There was no statistical significance in fever duration between the two groups (p > .05). Cough was two times (51.5% vs. 25%) and shortness of breath was four times more common (24.2% vs. 5.9%) in the group with pulmonary involvement versus no pulmonary involvement and the difference was statistically significant (p = .008 vs. p = .017, respectively). There was no statistical significance in headache, chest pain, fatigue, anosmia, diarrhea, sore throat, and myalgia between the two groups. Chest CT findings of children were summarized in Table 2 . Regarding lung involvement scores, 12 (36.4%) patients had a score of 1, 14 (42.4%) had a score of 2, 4 (12.1%) had a score of 3, 2 (6%) had a score of 4, and only 1 patient had a score of 5. (Table 2 ) 

As mentioned in Section 3, cough was two times (51.5% vs. 25%) and

shortness of breath was four times more common (24.2% vs. 5.9%) in the group with pulmonary involvement vs no pulmonary involvement and the difference was statistically significant (p = .008 vs. p = .017, respectively) ( Table 1 ). 

In this study, consistent with the literature, fever, and cough were the most common presenting symptoms, and CT findings were generally mild (Score 1 and Score 2). 1 While CRP, fibrinogen and ferritin levels differ significantly in patients with pulmonary involvement, ALC, ANC, LDH, D-dimer, PLT, procalcitonin, and ANC/ALC ratio were similar compared with the patients with no pulmonary findings.

In our study, only fibrinogen level was found to be an independent risk factor for pulmonary involvement on CT scans.

Studies regarding the immune response to COVID-19 in children are limited compared to adults. 2 As a result, the reason for the mild clinical picture in children is based on hypotheses only. One of the theories is children trigger a milder inflammatory response because they produce a more controlled immune response, have fewer comorbidities that predispose to a pre-existing pro-inflammatory state, and they have relatively lower viral loads. 2 Another theory is the age-related differences in ACE2, which is defined as a key factor of the inflammatory processes established in conditions such as lung injury and sepsis. 3 It was reported that a higher concentration of ACE2 in pneumocytes provides protection for the pediatric age group against the severe clinical manifestations of COVID-19. 4 Abbreviation: CT, computed tomography. a Extent of lung involvement was scored as a percentage of the total lung area: score 1, 1%-5% involvement; score 2, 6%-25% involvement; score 3, 26%-50% involvement; score 4, 51%-75% involvement; and score 5, greater than 75% involvement.

While severe cases in previously published studies were shown to have lower lymphocyte-, higher leukocyte-counts, and higher ANC/ALC ratio, 6-10 in our study these parameters were not significantly different which supports the course of the disease is somehow different from the adults. A meta-analysis reviewing the prognostic value of 36 laboratory parameters concluded that cohorts with high levels of white blood cell count, neutrophil count, D-dimer, fibrinogen, and procalcitonin were more likely to progress to severe disease. 11 Also, increased levels of serum ferritin were observed among nonsurvived patients compared with survived patients. 11, 12 Decreased lymphocyte count and LDH, which is released from cells upon damage of their cytoplasmic membrane, was shown to have a strong relationship with lung involvement and to be positively associated with CRP while negatively associated with lymphocyte count. 13, 14 In another study that included 11 COVID-19 infected adults and one adolescent, the relationship between lung injury (according to Murray score of ARDS 15 ) and laboratory findings were evaluated. Albumin, lymphocyte count and ratio, LDH, neutrophile ratio, and CRP were found to be highly correlated with acute lung injury. 16 A systematic review including 551 pediatric patients with laboratory-confirmed COVID-19 infection reported that only a small proportion of pediatric cases had abnormal laboratory results. While lymphocytosis (35%) and increased LDH (29%)

were the most prevalent laboratory abnormalities, increased CRP (17%), procalcitonin (10%), and D-dimer (12%) levels were less frequent. 1 Sun et al. 17 reported normal CRP levels in 37.5% of children requiring intensive care. In a review of 92 pediatric studies, while lymphocytosis was present in 44% of the children, the lymphocytopenia rate was only 17.5%. The low prevalence was explained by the high frequency of mild cases. 18 Whereas the laboratory changes are well-defined, little is known about their correlation with CT findings. Tan et al. 19 reported that CRP (R = .62; p < .01), and granulocyte/lymphocyte ratio (R = .49; p < .01) were positively associated with the CT severity scores while the number of lymphocytes (R = − .37; p < .01) was negatively correlated. The reason why the ANC/ALC ratio is not an indicator for lung involvement might be that the mean ALC values in both groups were in the normal ranges, possibly due to the mild course of disease in both groups consistent with the pediatric studies in the literature. In another study, CRP levels were found to be highly correlated with the diameter of lung lesions and severe presentation. 20 In our study, in addition to the literature, fibrinogen, and ferritin levels were also significant markers of lung involvement. We hypothesize that this finding is a result of the cytokines produced by macrophages, which constitute the highest number of immune cells in lung parenchyma. 21 During viral infections, the fever is a manifestation of the body's immune response to the viral replication to augment immunity. 22 However, if the viral infection is not restricted by the initial immune response, the course of the disease is complicated by the dysregulated inflammatory state and cytokine storm, manifested by persistent fever. On this basis, persistent high fever in COVID-19 is considered an indicator of severe infection and is associated with a higher likelihood of acute respiratory distress syndrome. 23 In our study, fever was not a factor affecting pulmonary involvement. The possible reason was that the fever response in all patients was shortterm and not persistent.

This study has several limitations. First, as a result of the retrospective design of the study, only the parameters obtained at the time of admission could be evaluated. Although the sample size is statistically sufficient, the study should be repeated in larger patient groups. Second, as this was a cross-sectional and retrospective study, ongoing changes in the laboratory parameters and CT images could not be evaluated.

In conclusion, fibrinogen may be useful to predict pulmonary involvement of COVID-19 in children. Restricting radiological imaging such as CT scans to patients with significant symptoms and high fibrinogen levels might be helpful in children with COVID-19

infections.

What we know so far about coronavirus disease 2019 in children: a meta-analysis of 551 laboratory-confirmed cases

SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings

ACE and ACE2 in inflammation: a tale of two enzymes

Will children reveal their secret? The coronavirus dilemma

Are children less susceptible to COVID-19?

Dysregulation of immune response in patients with COVID-19 in Wuhan, China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan

Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19

Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients

Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis

The clinical and chest CT features associated with severe and critical COVID-19 pneumonia

Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study

An expanded definition of the adult respiratory distress syndrome

Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury

Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study

Ten key points about COVID-19 in children: The shadows on the wall

C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early

C-reactive protein levels in the early stage of COVID-19

The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome

Fever management in intensive care patients with infections

Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China

Can laboratory findings predict pulmonary involvement in children with COVID-19 infection?

The authors received no financial support for the research, authorship, and/or publication of this article.

The authors declare that there are no conflict of interests. 

The data that support the findings of this study are available from the corresponding author upon reasonable request.